Themis Medicare Update by Epic Research

Themis Medicare has started supply of its research based product, for pain management (API – Aceclofenac based injection) to a Indian Pharma major, under long term agreement. Themis is the first company to develop this injection which is IPR protected.



Real Time News & Trading Trends Keep Liking #EpicResearch




Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH

Posted in: Indian Market Tips